Gene · 5345
Papers4,537
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
481 to 500 of 4,537
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Bioactive and Sensory Di- and Tripeptides Generated during Dry-Curing of Pork Meat. | Int J Mol Sci | 2023 | 36675084 | PubTator, text mining | PubMed |
| Distinguishing Plasmin-Generating Microvesicles: Tiny Messengers Involved in Fibrinolysis and Proteolysis. | Int J Mol Sci | 2023 | 36675082 | PubTator, text mining | PubMed |
| Posttranscriptional Regulation of the Plasminogen Activation System by Non-Coding RNA in Cancer. | Int J Mol Sci | 2023 | 36674481 | PubTator, text mining | PubMed |
| The Challenges and Prospects of p53-Based Therapies in Ovarian Cancer. | Biomolecules | 2023 | 36671544 | PubTator, text mining | PubMed |
| The potential impact of coagulation factor XIII in trauma-induced coagulopathy - a retrospective case series analysis. | Eur J Trauma Emerg Surg | 2023 | 36670303 | PubTator, text mining | PubMed |
| Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice. | Cardiovasc Res | 2023 | 36662542 | PubTator, text mining | PubMed |
| The novel biomarkers for assessing clinical benefits of continuous renal replacement therapy in pediatric sepsis: a pilot study. | Clin Proteomics | 2023 | 36650427 | PubTator, text mining | PubMed |
| A deeply conserved protease, acylamino acid-releasing enzyme (AARE), acts in ageing in Physcomitrella and Arabidopsis. | Commun Biol | 2023 | 36650210 | PubTator, text mining | PubMed |
| Synthetic Biology Design as a Paradigm Shift toward Manufacturing Affordable Adeno-Associated Virus Gene Therapies. | ACS Synth Biol | 2023 | 36627108 | PubTator, text mining | PubMed |
| Comparative tissue proteomics reveals unique action mechanisms of vaccine adjuvants. | iScience | 2023 | 36619976 | PubTator, text mining | PubMed |
| Association between acute disease severity and one-year quality of life among post-hospitalisation COVID-19 patients: Coalition VII prospective cohort study. | Intensive Care Med | 2023 | 36594987 | PubTator, text mining | PubMed |
| Inhibition of fibroblast activation protein ameliorates cartilage matrix degradation and osteoarthritis progression. | Bone Res | 2023 | 36588124 | PubTator, text mining | PubMed |
| A first-in-human study of the anti-inflammatory profibrinolytic TMS-007, an SMTP family triprenyl phenol. | Br J Clin Pharmacol | 2023 | 36562925 | PubTator, text mining | PubMed |
| A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome. | iScience | 2023 | 36507225 | PubTator, text mining | PubMed |
| Transglutaminase Activities of Blood Coagulant Factor XIII Are Dependent on the Activation Pathways and on the Substrates. | Thromb Haemost | 2023 | 36473493 | PubTator, text mining | PubMed |
| Gene expression associations with body mass index in the Multi-Ethnic Study of Atherosclerosis. | Int J Obes (Lond) | 2023 | 36463326 | PubTator, text mining | PubMed |
| Modifiable contributing factors to COVID-19: A comprehensive review. | Food Chem Toxicol | 2023 | 36450305 | PubTator, text mining | PubMed |
| A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study. | Lancet Haematol | 2023 | 36436542 | PubTator, text mining | PubMed |
| Using reported pathogenic variants to identify therapeutic opportunities for genetic diseases. | Mol Genet Genomic Med | 2023 | 36374045 | PubTator, text mining | PubMed |
| Triazol-1-yl Benzamides Promote Anticoagulant Activity via Inhibition of Factor XIIa. | Cardiovasc Hematol Agents Med Chem | 2023 | 36321236 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5345/papers?page=25